In a patent litigation among medical device manufacturers, CRA was asked to assess damages suffered by plaintiff for alleged infringement of patents on bone compression plates. CRA examined lost profit and reasonable royalty damages, finding that a royalty would have been capped at the cost of implementing a viable non-infringing alternative. CRA provided an expert report and deposition testimony.
Patent damages: Recent trends in Rule 702 decisions
Rule 702 decision trends are based on our review of available US district court decisions concerning damages experts in patent infringement matters that have...